Oral Testosterone With and Without Concomitant Inhibition of 5α-Reductase by Dutasteride in Hypogonadal Men for 28 Days

PURPOSE: Co-administration of the 5α-reductase inhibitor dutasteride increases the oral testosterone bioavailability in men with experimentally induced hypogonadism. We examined oral testosterone with and without dutasteride administration in hypogonadal men for 28 days. MATERIALS AND METHODS: We ra...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Urol
Main Authors: Amory, John K., Bush, Mark A., Zhi, Hui, Caricofe, Ralph B., Matsumoto, Alvin M., Swerdloff, Ronald S., Wang, Christina, Clark, Richard V.
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4267472/
https://ncbi.nlm.nih.gov/pubmed/21168874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2010.09.089
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares